Formulation evidence map · Published July 22, 2026 · Sources checked July 22, 2026

NeuroAxis research kit overview

NeuroAxis is a multi-component catalog kit. No cited primary study evaluated the exact kit, its component interactions, or a unified outcome.

Evidence boundary: ingredient studies do not establish the behavior of this exact formulation. The catalog product is supplied only for qualified in vitro laboratory research and is not for human or animal use.

What is NeuroAxis kit?

Cerebrolysin is a complex peptide preparation, BPC-157 and TB-500-related materials have largely preclinical tissue literature, and Selank has predominantly rodent behavioral research.

Research category
Formulations & research kits
Study models represented
Ingredient-level cell, animal, and selected clinical studies
Names in the literature
NeuroAxis Special
Primary boundary
No direct evidence for the exact kit, combined mechanism, safety, or efficacy.

What does the selected evidence support?

Different model systems and material classes cannot be combined into one neurological-effect claim.

Primary sources

  1. Woo et al. (2020) — Cerebrolysin randomized pilot with a null primary result; not a kit study. DOI: 10.1186/s12883-020-01908-9
  2. Chang et al. (2011) — BPC-157 preclinical research; not a kit study. DOI: 10.1152/japplphysiol.00945.2010
  3. Kasian et al. (2017) — Selank rat research; not a kit study. DOI: 10.1155/2017/5091027

Ingredient evidence reviews

Research literature and product documentation are different

A publication describes a study and its results. A batch-specific Certificate of Analysis documents characteristics of a supplied research material. One does not substitute for the other.

Review NeuroAxis kit product specifications · Browse the COA library · Read the research-use policy

Prepared by The Pep Labs Research Editorial Team. This evidence summary is not medical advice and contains no dosing or administration guidance.